A triplet treatment plus autologous stem-cell transplantation was associated with longer progression... Adding a monoclonal antibody to a triplet treatment significantly lowered the risk of disease... Adding ixazomib to pomalidomide and dexamethasone improved progression-free survival rates... Of 23 patients, three achieved complete remission and 15 achieved complete remission with incomplete hematological recovery.